Skip to main content
Log in

BMI Is a Risk Factor for Colorectal Cancer Mortality

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The relationship between dietary and lifestyle risk factors and long-term mortality from colorectal cancer is poorly understood. Several factors, such as obesity, intakes of red meat, and use of aspirin, have been reported to be associated with risk of colorectal cancer mortality, though these findings have not been replicated in all studies to date.

Methods

In the Minnesota Colon Cancer Control Study, 46,551 participants 50–80 years old were randomly assigned to usual care (control) or annual or biennial screening by fecal occult blood testing. Colon cancer mortality was assessed after 30 years of follow-up. Dietary intake and lifestyle risk factors were assessed by questionnaire at baseline.

Results

Age [hazard ratio (HR) 1.09; 95% CI 1.07, −1.11], male sex (HR 1.25; 95% CI 1.01, 1.57), and higher body mass index (BMI) (HR 1.03; 95% CI 1.00–1.05) increased the risk of CRC mortality, while undergoing screening for CRC was associated with a reduced risk of colorectal cancer mortality (HR 0.76; 95% CI 0.61–0.94 and 0.67; 95% CI 0.53–0.83 for biennial and annual screening, respectively). Intakes of grains, meats, proteins, coffee, alcohol, aspirin, fiber, fruits, and vegetables were not associated with colorectal cancer mortality.

Conclusions

Our study confirms the relationship between BMI and long-term colorectal cancer mortality. Modulation of BMI may reduce risk of CRC mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  2. Tarraga Lopez PJ, Albero JS, Rodriguez-Montes JA. Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol. 2014;7:33–46.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG. Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev. 2014;15:434–451.

    Article  PubMed  Google Scholar 

  4. McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol. 2013;31:2773–2782.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891–1904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148:904–914.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007–1013.

    Article  CAS  PubMed  Google Scholar 

  8. Tamakoshi A, Lin Y, Kawado M, Yagyu K, Kikuchi S, Iso H. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26:285–293.

    Article  PubMed  Google Scholar 

  9. Cai S, Li Y, Ding Y, Chen K, Jin M. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev. 2014;23:532–539.

    Article  CAS  PubMed  Google Scholar 

  10. Breslow RA, Chen CM, Graubard BI, Mukamal KJ. Prospective study of alcohol consumption quantity and frequency and cancer-specific mortality in the US population. Am J Epidemiol. 2011;174:1044–1053.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gilbertsen V. Colon cancer screening: the Minnesota experience. Gastrointest Endosc. 1980;26:31S–32S.

    Article  CAS  PubMed  Google Scholar 

  12. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371.

    Article  CAS  PubMed  Google Scholar 

  13. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.

    Article  CAS  PubMed  Google Scholar 

  14. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.

    Article  Google Scholar 

  15. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd ed. London: Wiley; 2002.

    Google Scholar 

  16. Buuren SV, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1.

    Article  Google Scholar 

  17. Horvitz D, Thompson D. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc. 1952;47:663–685.

    Article  Google Scholar 

  18. Efron B, Tibshirani R. Cross validation and the bootstrap: estimating the error rate of a prediction rule. Technical report 176, Department of Statistics, Stanford University; 1995.

  19. Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44:634–647.

    Article  CAS  PubMed  Google Scholar 

  20. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933–947.

    Article  CAS  PubMed  Google Scholar 

  21. Ho GY, Wang T, Gunter MJ, et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res. 2012;72:3029–3037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Xu XT, Xu Q, Tong JL, et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis. 2011;12:234–244.

    Article  CAS  PubMed  Google Scholar 

  23. Winzer BM, Whiteman DC, Reeves MM, Paratz JD. Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control. 2011;22:811–826.

    Article  PubMed  Google Scholar 

  24. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–578.

    Article  PubMed  Google Scholar 

  25. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31–41.

    Article  CAS  PubMed  Google Scholar 

  26. Li P, Wu H, Zhang H, et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. 2014;64:1419.

    Article  PubMed  Google Scholar 

  27. Cardwell CR, Kunzmann AT, Cantwell MM, et al. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort. Gastroenterology. 2014;146:700-8e2.

    Article  Google Scholar 

  28. Domingo E, Church DN, Sieber O, et al. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol. 2013;31:4297–4305.

    Article  CAS  PubMed  Google Scholar 

  29. Nishihara R, Lochhead P, Kuchiba A, et al. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013;309:2563–2571.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hsing AW, McLaughlin JK, Schuman LM, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990;50:6836–6840.

    CAS  PubMed  Google Scholar 

  31. German RR, Fink AK, Heron M, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 2011;35:126–131.

    Article  PubMed  Google Scholar 

  32. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study. J Clin Epidemiol. 1999;52:447–452.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are indebted to Erik Bjelke for the foresight to add this questionnaire to the study and for initiating the work associated with administering it. We also thank the following research staff: Deborah Engelhard, Jill Cordes, Mindy Geisser, and Gavin Watt; and the residents of Minnesota and Wisconsin that participated in this study.

Funding

This study was funded by Veterans Affairs Merit Program EPID-007-09S and research contracts from National Institutes of Health/National Cancer Institute and Grants N01CB95613, N01CB61005, N01CB53862, and R01CA65728.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aasma Shaukat.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shaukat, A., Dostal, A., Menk, J. et al. BMI Is a Risk Factor for Colorectal Cancer Mortality. Dig Dis Sci 62, 2511–2517 (2017). https://doi.org/10.1007/s10620-017-4682-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4682-z

Keywords

Navigation